Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 313, pseudogene (RNU6-313P) is a pseudogene of the U6 small nuclear RNA, annotated as non-coding and non-functional in the canonical sense, and is located on human chromosome 7q11.21[2][4]. U6 small nuclear RNA (snRNA) itself is a highly conserved component of the spliceosome complex, essential for the splicing of pre-mRNA in eukaryotic cells[1][3]. However, RNU6-313P is specifically categorized as a pseudogene, meaning it is a genomic sequence similar to functional genes but is generally not expressed as a functional RNA or protein. It is considered a remnant or byproduct of retrotransposition events involving LINE elements, with no currently known biological or disease-related function or role in therapeutics[2][5]. Pseudogenes like RNU6-313P are not considered therapeutic targets, and there are no drugs, biomarkers, or known safety concerns associated with them[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 313, pseudogene (RNU6-313P).